Christoph Michalski
0000-0003-3520-1040
Publication & Citation Trends
Publications
0 total
The PREOPANC-2 trial in resectable and borderline resectable pancreatic cancer.
Cited by 0
Semantic Scholar
Improving long-term outcomes in resectable pancreatic cancer
Cited by 0
Semantic Scholar
Non-inferiority of robotic versus open pancreatoduodenectomy — a systematic review and meta-analysis of prospective non-randomized and randomized trials
Cited by 0
Semantic Scholar
Extrachromosomal DNAs (ecDNAs) are associated with resistance to targeted therapies in pancreatic cancer
Cited by 0
Semantic Scholar
Reply to: Adjuvant Treatment Options and Modalities in Pancreatic Adenocarcinoma: Insights From ESPAC4.
Cited by 1
Semantic Scholar
Preliminary results from a Genome-Wide Association Study of pancreatic neuroendocrine neoplasms identify novel susceptibility loci
Cited by 0
Semantic Scholar
Unveiling the intriguing relationship: oncogenic KRAS , morphological shifts, and mutational complexity in pancreatic mucinous cystic neoplasms OA
Cited by 3
Semantic Scholar
New implications from long-term outcomes of perioperative therapy in resectable pancreatic cancer
Cited by 0
Semantic Scholar
Research Topics
Pancreatic and Hepatic Oncology Research
(196)
Pancreatitis Pathology and Treatment
(84)
Cancer Genomics and Diagnostics
(42)
Renal cell carcinoma treatment
(40)
Neuroendocrine Tumor Research Advances
(33)
Affiliations
BMW (Germany)
German Society of Surgery
Universität Hamburg
Oregon Health & Science University
Munich University of Applied Sciences